Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasmodium Falciparum, Malaria”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02207816
What this trial is testing

An Extension to Study MALARIA-055 PRI (NCT00866619) to Evaluate the Long-term Efficacy, Safety and Immunogenicity of GSK Biologicals' Candidate Malaria Vaccine in Infants and Children in Africa

Who this might be right for
Malaria
GlaxoSmithKline 3,084
Post-approval studies (Phase 4)UnknownNCT00137566
What this trial is testing

The Effect of Paracetamol in the Treatment of Non-severe Malaria in Children in Guinea-Bissau

Who this might be right for
MalariaFalciparum
Bandim Health Project
Not applicableStudy completedNCT03855995
What this trial is testing

A Study Assessing the Safety, Efficacy, and Impact of GlaxoSmithKline Biologicals' RTS, S/AS01E Malaria Vaccine in Young Children Across Sub-Saharan Africa

Who this might be right for
MalariaMalaria Vaccines
GlaxoSmithKline 77,953
Post-approval studies (Phase 4)Study completedNCT00137657
What this trial is testing

Impact of Cotrimoxazole Prophylaxis for HIV-Infected Adults on Antifolate Resistance

Who this might be right for
HIVMalariaDiarrhea+2 more
Centers for Disease Control and Prevention 1,478
Not applicableStudy completedNCT01163877
What this trial is testing

Iron Absorption and Utilization in Adolescents Infected With Malaria Parasites, Hookworms or Schistosoma

Who this might be right for
Malaria, FalciparumHookworm InfectionsSchistosoma Haematobium
Swiss Federal Institute of Technology 43
Not applicableStudy completedNCT04412005
What this trial is testing

Pregnant Women for Malaria Surveillance

Who this might be right for
P. Falciparum
Barcelona Institute for Global Health 16,958
Early research (Phase 1)Study completedNCT02431637
What this trial is testing

Experimental Falciparum Transmission to Anopheles

Who this might be right for
Malaria
Medicines for Malaria Venture 6
Post-approval studies (Phase 4)Study completedNCT02741024
What this trial is testing

Efficacy of Artesunate-amodiaquine and Artemether-lumefantrine for Uncomplicated Malaria in South Kivu, DR Congo

Who this might be right for
Malaria
Medecins Sans Frontieres, Netherlands 288
Not applicableStudy completedNCT00766662
What this trial is testing

Intermittent Preventive Treatment in Infant in Mali

Who this might be right for
Malaria
University of Bamako
Post-approval studies (Phase 4)Study completedNCT05244954
What this trial is testing

Comparing Chemoprevention Approaches for School-based Malaria Control

Who this might be right for
Malaria,FalciparumAnemia in Children
University of Maryland, Baltimore 746
Post-approval studies (Phase 4)Study completedNCT03352843
What this trial is testing

Single Low-dose Primaquine Efficacy and Safety.

Who this might be right for
Malaria
Tropical Pesticides Research Institute, Tanzania 157
Post-approval studies (Phase 4)UnknownNCT00238017
What this trial is testing

Efficacy and Safety of Amodiaquine and Amodiaquine-Artesunate

Who this might be right for
Malaria
Charite University, Berlin, Germany 400
Large-scale testing (Phase 3)Study completedNCT00709969
What this trial is testing

Evaluation of Safety and Efficacy of Artemether-Lumefantrine Tablets in African Infants and Children With Uncomplicated P. Falciparum Malaria

Who this might be right for
Plasmodium Falciparum Malaria
Novartis 310
Post-approval studies (Phase 4)Study completedNCT03201770
What this trial is testing

Cohort Event Monitoring Study of Pyramax®

Who this might be right for
Malaria,Falciparum
Shin Poong Pharmaceutical Co. Ltd. 8,572
Early research (Phase 1)Study completedNCT02859350
What this trial is testing

Safety, Tolerability and Immunogenicity of PfSPZ Vaccine in an Age De-escalation Trial in Equatorial Guinea.

Who this might be right for
Malaria
Sanaria Inc. 135
Early research (Phase 1)Study completedNCT01169077
What this trial is testing

EP1300 Polyepitope DNA Vaccine Against Plasmodium Falciparum Malaria

Who this might be right for
Plasmodium Falciparum Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 39
Early research (Phase 1)Ended earlyNCT04130282
What this trial is testing

VAC077: Safety and Immunogenicity of the Pfs25-IMX313/Matrix-M Vaccine

Who this might be right for
Malaria,Falciparum
University of Oxford 1
Post-approval studies (Phase 4)Study completedNCT02325180
What this trial is testing

Artemisinin-based Combination Therapy for Treatment of Plasmodium Falciparum Malaria in North Sumatera, Indonesia

Who this might be right for
Malaria, Falciparum
London School of Hygiene and Tropical Medicine 338
Testing effectiveness (Phase 2)Study completedNCT01666925
What this trial is testing

Efficacy of Malaria Vaccines in Kenyan Adults

Who this might be right for
Malaria
University of Oxford 120
Post-approval studies (Phase 4)Not Yet RecruitingNCT07713602
What this trial is testing

Study to Assess Safety and Clinical Responses With Coartem® Baby Dispersible Tablets in Paediatric Patients Weighing 2 to <5 kg With Uncomplicated Malaria

Who this might be right for
Malaria
Novartis Pharmaceuticals 20
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation